Cassava Sciences Inc. is a biotechnology company that focuses on developing novel drug candidates to treat psychiatric and neurological conditions, including Alzheimer’s disease. With a strong pipeline and innovative approach, the company aims to revolutionize the treatment landscape and improve patients’ quality of life.
